Latest Insider Transactions at Brp Group, Inc. (BRP)
This section provides a real-time view of insider transactions for Brp Group, Inc. (BRP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BRP Group, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BRP Group, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2024
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
85,222
-25.07%
|
$3,494,102
$41.5 P/Share
|
|
Aug 09
2024
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
56,912
-14.34%
|
$2,333,392
$41.92 P/Share
|
|
Aug 08
2024
|
Seth Bala Cohen General Counsel |
SELL
Open market or private sale
|
Direct |
3,783
-30.03%
|
$158,886
$42.63 P/Share
|
|
Aug 08
2024
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
36,684
-4.32%
|
$1,540,728
$42.03 P/Share
|
|
Aug 08
2024
|
James Morgan Roche Officer |
BUY
Conversion of derivative security
|
Direct |
200,000
+31.57%
|
-
|
|
Aug 08
2024
|
James Morgan Roche Officer |
SELL
Conversion of derivative security
|
Direct |
200,000
-13.92%
|
-
|
|
Aug 01
2024
|
Seth Bala Cohen General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,217
-8.81%
|
$52,331
$43.21 P/Share
|
|
Jul 01
2024
|
Jay A Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+4.36%
|
-
|
|
Jul 01
2024
|
Joseph John Kadow Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+4.04%
|
-
|
|
Jul 01
2024
|
Barbara Ruth Matas Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+4.04%
|
-
|
|
Jul 01
2024
|
Sathish Muthukrishnan Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+13.06%
|
-
|
|
Jul 01
2024
|
Sunita Parasuraman Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+6.53%
|
-
|
|
Jul 01
2024
|
Ellyn Shook Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+6.53%
|
-
|
|
Jul 01
2024
|
Myron K Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+6.53%
|
-
|
|
Jul 01
2024
|
Chris Thomas Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+0.57%
|
-
|
|
May 21
2024
|
Baldwin Insurance Group Holdings, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
125,000
-0.94%
|
-
|
|
May 21
2024
|
Lowry Baldwin Director |
SELL
Open market or private sale
|
Indirect |
125,000
-62.84%
|
$4,125,000
$33.96 P/Share
|
|
May 21
2024
|
Lowry Baldwin Director |
BUY
Conversion of derivative security
|
Indirect |
125,000
+50.0%
|
-
|
|
May 21
2024
|
Lowry Baldwin Director |
SELL
Conversion of derivative security
|
Indirect |
125,000
-100.0%
|
-
|
|
May 21
2024
|
Lowry Baldwin Director |
BUY
Other acquisition or disposition
|
Indirect |
125,000
+50.0%
|
-
|
|
May 21
2024
|
Lowry Baldwin Director |
SELL
Other acquisition or disposition
|
Indirect |
125,000
-0.94%
|
-
|
|
May 13
2024
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.1%
|
$150,000
$30.61 P/Share
|
|
May 10
2024
|
Daniel Galbraith Officer |
SELL
Open market or private sale
|
Direct |
24,841
-79.81%
|
$745,230
$30.11 P/Share
|
|
May 10
2024
|
Daniel Galbraith Officer |
SELL
Open market or private sale
|
Indirect |
80,932
-100.0%
|
$2,347,028
$29.83 P/Share
|
|
May 09
2024
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
20,000
-3.9%
|
$600,000
$30.29 P/Share
|
|
May 09
2024
|
Daniel Galbraith Officer |
SELL
Open market or private sale
|
Direct |
1,040
-3.23%
|
$31,200
$30.76 P/Share
|
|
May 09
2024
|
Daniel Galbraith Officer |
SELL
Open market or private sale
|
Indirect |
74,668
-25.02%
|
$2,240,040
$30.25 P/Share
|
|
May 09
2024
|
Daniel Galbraith Officer |
BUY
Conversion of derivative security
|
Indirect |
155,600
+50.0%
|
-
|
|
May 09
2024
|
Daniel Galbraith Officer |
SELL
Conversion of derivative security
|
Indirect |
155,600
-11.4%
|
-
|
|
May 09
2024
|
Seth Bala Cohen General Counsel |
SELL
Open market or private sale
|
Direct |
10,834
-43.96%
|
$325,020
$30.03 P/Share
|
|
Apr 01
2024
|
Laura Sherman |
SELL
Payment of exercise price or tax liability
|
Direct |
186
-10.95%
|
$5,208
$28.55 P/Share
|
|
Apr 01
2024
|
Daniel Galbraith Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,223
-29.13%
|
$370,244
$28.55 P/Share
|
|
Apr 01
2024
|
Daniel Galbraith Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,633
+45.33%
|
-
|
|
Apr 01
2024
|
Joseph John Kadow Director |
BUY
Grant, award, or other acquisition
|
Direct |
639
+4.89%
|
-
|
|
Apr 01
2024
|
Corbyn N. Galloway Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,438
-5.19%
|
$124,264
$28.55 P/Share
|
|
Apr 01
2024
|
Corbyn N. Galloway Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,503
+11.15%
|
-
|
|
Apr 01
2024
|
James Morgan Roche Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,135
-5.88%
|
$451,780
$28.55 P/Share
|
|
Apr 01
2024
|
James Morgan Roche Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,369
+12.26%
|
-
|
|
Apr 01
2024
|
Trevor Baldwin Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
24,606
-27.07%
|
$688,968
$28.55 P/Share
|
|
Apr 01
2024
|
Trevor Baldwin Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,917
+44.85%
|
-
|
|
Apr 01
2024
|
Jay A Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
639
+5.28%
|
-
|
|
Apr 01
2024
|
Barbara Ruth Matas Director |
BUY
Grant, award, or other acquisition
|
Direct |
639
+4.89%
|
-
|
|
Apr 01
2024
|
Seth Bala Cohen General Counsel |
SELL
Other acquisition or disposition
|
Direct |
60
-0.24%
|
$1,680
$28.55 P/Share
|
|
Apr 01
2024
|
Seth Bala Cohen General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
17,605
+24.24%
|
-
|
|
Apr 01
2024
|
Seth Bala Cohen General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,555
-14.3%
|
$99,540
$28.55 P/Share
|
|
Apr 01
2024
|
Bradford Hale Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,470
-11.08%
|
$377,160
$28.55 P/Share
|
|
Apr 01
2024
|
Bradford Hale Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,246
+23.93%
|
-
|
|
Apr 01
2024
|
Sathish Muthukrishnan Director |
BUY
Grant, award, or other acquisition
|
Direct |
639
+17.12%
|
-
|
|
Apr 01
2024
|
Sunita Parasuraman Director |
BUY
Grant, award, or other acquisition
|
Direct |
639
+8.06%
|
-
|
|
Apr 01
2024
|
Ellyn Shook Director |
BUY
Grant, award, or other acquisition
|
Direct |
639
+8.06%
|
-
|